A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies

BACKGROUND: Docetaxel is a taxane anticancer drug used in a wide variety of solid tumors. Liposomes are versatile drug carriers that may increase drug solubility, serve as sustained release systems, provide protection from drug degradation and toxicities, and help overcome multidrug resistance. This...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Deeken, John F., Slack, Rebecca, Weiss, Glen J., Ramanathan, Ramesh K., Pishvaian, Michael J., Hwang, Jimmy, Lewandowski, Karen, Subramaniam, Deepa, He, Aiwu Ruth, Cotarla, Ion, Rahman, Aquilur, Marshall, John L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3703246/
https://ncbi.nlm.nih.gov/pubmed/23274395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-012-2048-y
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller